Adele M. Gulfo
Currently, Adele M. Gulfo is Board of Advisor at 1843 Capital LLC. Ms. Gulfo is also on the board of EnPro Industries, Inc., Medexus Pharmaceuticals, Inc. and Myovant Sciences Ltd. and Chief Business & Commercial Development Officer at Sumitovant Biopharma, Inc.
Adele M. Gulfo previously occupied the position of President-Latin America Region at Pfizer Inc., Chairman-Commercial Development at Roivant Sciences Ltd., EVP-Global Collaboration & Strategic Operations at Mylan, Inc. and EVP & Head of Global Commercial Development at Mylan NV.
Adele M. Gulfo received an undergraduate degree from Seton Hall University, an MBA from Fairleigh Dickinson University and a graduate degree from the University of Medicine & Dentistry of New Jersey.
Transactions
Date
Transaction
Value
| 12/20/2022 | 1,168 | 0 | |
| 09/16/2022 | 10,052 | 0 | |
| 06/27/2022 | 1,921 | 0 | |
| 01/20/2022 | 5,135 | 0 | |
| 01/20/2022 | 5,135 | 0 | |
| 01/20/2022 | 5,135 | 0 | |
| 01/20/2022 | 5,135 | 0 | |
| 01/10/2022 | 5,135 | 0 | |
| 12/24/2021 | 1,149 | 0 | |
| 10/01/2021 | 4,396 | 13,231 | |
| 09/23/2021 | 4,012 | 0 | |
| 07/01/2021 | 1,966 | 13,997 | |
| 06/28/2021 | 1,723 | 0 | |
| 04/01/2021 | 1,958 | 0 | |
| 12/19/2020 | 1,071 | 0 | |
| 06/25/2020 | 1,819 | 0 | |
| 06/25/2020 | 2,150 | 0 | |
| 06/25/2020 | 2,150 | 0 | |
| 06/25/2019 | 0 | 0 |
